[spacer image]
BD
[spacer image]
[spacer image]

Did you know?
[spacer image] The all-cotton elastic bandage now known as the ACE® bandage has been marketed by BD since 1913. Learn more about BD's history » [spacer image]
[spacer image]

BD Global Initiatives
Print
[spacer image]


Enhancing Pharmaceutical Therapies

Innovation and a commitment to advancing research help BD remain at the leading edge of drug discovery, production and delivery.

Discovery and Development

BD’s contributions to drug discovery can be traced to the very first commercial flow cytometer, which the Company brought to market in 1973. Today, major pharmaceutical companies as well as medical and academic research centers the world over use BD flow cytometry platforms – including cell sorters, analyzers, software and reagents – to identify cells and better understand their functions and the effects new drug candidates have on them.

BD™ Phosflow technologyResearchers use BD™ Phosflow technology to analyze cell signaling pathways to understand how experimental drugs might impact these pathways and inhibit the spread of disease. BD Cytometric Bead Arrays allow researchers to analyze multiple markers at the same time, increasing efficiency and delivering more results from smaller samples.

BD’s growing line of drug metabolism assays help screen out nonviable drug candidates early, increasing the ultimate likelihood of clinical trial success. In addition, the Company’s broad array of laboratory products for tissue culture and fluid handling are utilized in research laboratories globally.

BD also helps pharmaceutical and biotechnology customers and partners develop new medicines tailored to specific patient sub-populations by collaborating on the development of biomarkers and companion diagnostic assays.

Visit www.bdbiosciences.com

Biopharmaceutical Production

Drug production is undergoing a major change, as generations of chemically derived small molecule drugs are joined by newer, biologically derived large molecule therapies. In response, BD established a new product platform, Advanced Bioprocessing (US), to enable the industry to produce higher volumes of biopharmaceuticals efficiently and safely. With its high-quality, consistent cell culture media supplements already used in 19 drugs and vaccines, BD is expanding its product scope and adding production capacity.

Drug Delivery

When the most demanding pharmaceutical and biotechnology companies look for better ways to deliver injectable drugs and vaccines, they turn to BD – the world’s leading provider of prefillable drug delivery systems. To meet the growing demand for BD Hypak™ SCF – sterile, clean, ready-to-fill – Glass Prefillable Syringes, BD is making significant investments in high-volume manufacturing, while also enhancing quality and providing customized systems that respond to the specific requirements of each drug or vaccine. BD also continues to invest in advanced injectable drug delivery systems by developing novel prefillable "Micro-Delivery" devices and self-injection devices for chronic therapies.

 


[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]